HOME ABOUT UNITED KINGDOM INTERNATIONAL SERVICE HISTORY FOUNDER & CHAIRMAN PRODUCTS COMMUNITY AWARDS NEWS & BLOG CAREERS VACANCIES CONTACT US History The Morningside Companies' Proud Past Origins in Exports 1991 to 2004 Founded in 1991 Focus on supply to private sector export markets in developing countries Established a reputation for excellence and reliability of supply with NGOs and major UN aid agencies First UK Marketing Authorisation (2005): Metformin Tablets Picture: The Morningside Team at their stand, during an International Exhibition. Growth in the UK & Export Markets 2005 to 2012 Established a sales & marketing, Quality Assurance and regulatory presence in the UK First third party contract supply order (2006) Focus on niche, high-value molecules 50+ Marketing Authorisations secured Growing infrastructure with the addition of three distribution centres Building an international and UK distribution network Picture: Morningside customers during an event in Guyana, South America. Intellectual Property Led Growth 2012 to 2016 Morningside wins the Queen’s Award for Innovation: International Trade 2012 The Morningside companies establish a Research & Development capability. The first product launched with full IP ownership (Sodium Fluoride Toothpaste: 2015) Completed substantial marketing investment to launch the Headline Brand range Development of supply to NHS hospitals, driving high growth and consistent supply Further investment in infrastructure and new GMP approved buildings Picture: Morningside’s Distribution Centre, in Loughborough, United Kingdom. Sector Leading Success 2016 to Today Prime Minister Theresa May hails Morningside as ‘the best of British’ during a trade mission to India (2016) Morningside wins the Innovation in Generics Award at the Pharmacy Business Awards (2017) The Leicester Arena is renamed the Morningside Arena, as part of a major naming-rights deal (2018) Focus on key therapeutic areas Over 242 generic and branded licensed medicines in the UK and EU Significant opportunity to expand into new global markets Board of Trade Award received from former Secretary of State for International Trade, Dr Liam Fox (2018) Our Chief Executive, Dr Nik Kotecha OBE, was named Entrepreneur of the Year at the 2019 Lloyds Bank National Business Awards and the national Innovation Entrepreneur of the Year at the 2019 Great British Entrepreneur Awards In 2020, as part of the business’ continued expansion, a 5th office and warehousing unit was officially opened at our Loughborough site In 2020 Morningside Pharmaceuticals gained Full Authorised Economic Operator (AEO F) status from HMRC About this site © 2021 Morningside Pharmaceuticals Ltd. All rights reserved Registered in England No: 2672877 Postal address: 5 Pavilion Way, Castle Business Park, Loughborough, Leicestershire, LE11 5GW United Kingdom Quicklinks About Products Community News & Blog Careers Contact Us Social Media Home Privacy Policy Modern Slavery Statement Competition Law Compliance Terms & Conditions Sitemap Contact Us Website by Seed This website uses cookies to help deliver and improve our services and provide you with a much richer experience during your visit. Accept Read More